Brief: Optinose Inc Completes Patient Recruitment In Second Pivotal Trial
28/10/2021 14:39
Oct 28 (Reuters) - OptiNose Inc OPTN.O :
* OPTINOSE COMPLETES PATIENT RECRUITMENT IN SECOND PIVOTAL TRIAL FOR XHANCE
IN
CHRONIC SINUSITIS
* OPTINOSE INC - COMPANY EXPECTS TOP-LINE RESULTS IN Q2 2022
Source text for Eikon: ID:nGNXSF17J
Further company coverage: OPTN.O
Recent news on OptiNose
See all newsOptiNose Inc reports results for the quarter ended March 31 - Earnings Summary
OptiNose Inc expected to post a loss of 74 cents a share - Earnings Preview
Brief: OptiNose Q4 Income From Operations USD 354 Thousand
U.S. RESEARCH ROUNDUP-Darden Restaurants, Nike, Optinose
U.S. STOCKS ON THE MOVE-Accenture, Nike, FedEx